Related Experiment Videos

Insulin receptor substrate protein p53 localization in rats suggests mechanism for specific polyglutamine

E A Thomas1, P E Foye, C E Alvarez

  • 1Department of Molecular Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA.

Neuroscience Letters
|August 22, 2001
PubMed

Insights

Dentatorubral-pallidoluysian atrophy (DRPLA) is a neurodegenerative disease linked to the DRPLA gene. The study found IRSp53 protein expression in brain regions affected by DRPLA, suggesting its role in the disease.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Dentatorubral-pallidoluysian atrophy (DRPLA) is a neurodegenerative disorder caused by CAG repeat expansions in the DRPLA gene.
  • Atrophin-1, the DRPLA gene product, interacts with the insulin receptor tyrosine kinase substrate protein, IRSp53.

Purpose of the Study:

  • To investigate the expression patterns of IRSp53 in the rat central nervous system.
  • To explore the potential role of IRSp53 in the region-specific neurodegeneration observed in DRPLA.

Main Methods:

  • Isolation of rat and mouse cDNA clones for IRSp53.
  • In situ hybridization analysis to determine IRSp53 mRNA expression patterns in the rat brain.

Main Results:

  • IRSp53 mRNA was highly expressed in rat forebrain regions: cerebral cortex, striatum, hippocampus, and olfactory bulb.
  • Significant IRSp53 expression was also observed in the cerebellum, subthalamic nucleus, pons, amygdala, and hypothalamus.
  • Expression patterns of IRSp53 overlapped with brain regions known to degenerate in DRPLA.

Conclusions:

  • The findings suggest that insulin and insulin growth factor-1 signaling may play a regionally specific role in neurotransmission.
  • IRSp53's expression in DRPLA-affected areas supports its relevance as an atrophin-1 binding protein and a potential contributor to region-specific neurodegeneration.

Related Concept Videos